This is a table of type unigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
unigram | frequency |
---|---|
patients | 17314 |
cells | 9121 |
cell | 7772 |
cd | 6726 |
disease | 4640 |
results | 4100 |
treatment | 3884 |
patient | 3743 |
years | 3301 |
hsct | 3294 |
study | 3263 |
median | 3042 |
group | 2909 |
associated | 2841 |
infection | 2731 |
cases | 2686 |
age | 2675 |
expression | 2668 |
clinical | 2606 |
transplantation | 2596 |
one | 2556 |
therapy | 2548 |
transplant | 2532 |
gvhd | 2477 |
high | 2455 |
months | 2445 |
days | 2400 |
risk | 2349 |
may | 2271 |
ebv | 2252 |
virus | 2222 |
blood | 2180 |
also | 2169 |
two | 2165 |
immune | 2149 |
using | 2149 |
received | 2139 |
stem | 2137 |
day | 2128 |
analysis | 2099 |
diagnosis | 2079 |
time | 2046 |
acute | 2006 |
infections | 1994 |
il | 1984 |
donor | 1960 |
children | 1942 |
mg | 1926 |
response | 1914 |
showed | 1871 |
used | 1861 |
range | 1851 |
levels | 1801 |
survival | 1799 |
significant | 1798 |
year | 1786 |
data | 1785 |
compared | 1713 |
post | 1708 |
first | 1690 |
performed | 1665 |
case | 1661 |
specific | 1657 |
severe | 1655 |
vs | 1609 |
however | 1606 |
non | 1580 |
tumor | 1556 |
methods | 1556 |
increased | 1551 |
human | 1543 |
respectively | 1528 |
found | 1525 |
primary | 1516 |
well | 1502 |
positive | 1500 |
related | 1492 |
viral | 1485 |
method | 1482 |
kg | 1464 |
i | 1448 |
pts | 1445 |
due | 1444 |
anti | 1442 |
higher | 1433 |
low | 1424 |
cmv | 1421 |
conclusion | 1413 |
gene | 1409 |
significantly | 1394 |
observed | 1383 |
based | 1370 |
chronic | 1361 |
protein | 1360 |
including | 1349 |
treated | 1346 |
dose | 1341 |
conditioning | 1332 |
background | 1331 |
syndrome | 1330 |
without | 1324 |
normal | 1300 |
relapse | 1296 |
graft | 1268 |
studies | 1241 |
role | 1227 |
activity | 1227 |
different | 1221 |
allogeneic | 1220 |
reported | 1202 |
developed | 1184 |
multiple | 1181 |
grade | 1180 |
bone | 1170 |
cancer | 1157 |
pediatric | 1156 |
use | 1156 |
early | 1150 |
negative | 1144 |
number | 1136 |
objective | 1134 |
function | 1128 |
incidence | 1124 |
marrow | 1120 |
three | 1098 |
renal | 1095 |
overall | 1093 |
total | 1091 |
follow | 1088 |
type | 1074 |
lymphoma | 1071 |
groups | 1069 |
control | 1063 |
included | 1052 |
old | 1041 |
hospital | 1036 |
identified | 1034 |
conclusions | 1031 |
mice | 1030 |
os | 1027 |
hematopoietic | 1025 |
present | 1014 |
mortality | 993 |
following | 983 |
allo | 978 |
revealed | 973 |
report | 968 |
diagnosed | 967 |
disclosure | 957 |
prophylaxis | 950 |
ml | 950 |
donors | 948 |
development | 945 |
hla | 943 |
dna | 940 |
igg | 937 |
ci | 934 |
activation | 929 |
effect | 920 |
mean | 915 |
level | 915 |
factors | 914 |
peripheral | 911 |
mutations | 905 |
regimen | 903 |
genetic | 900 |
lower | 898 |
chemotherapy | 897 |
system | 894 |
leukemia | 886 |
common | 886 |
rate | 874 |
hct | 868 |
reduced | 866 |
mutation | 866 |
presented | 862 |
analyzed | 856 |
among | 852 |
failure | 851 |
deficiency | 850 |
effects | 843 |
factor | 843 |
sct | 839 |
induced | 829 |
serum | 824 |
prior | 819 |
antibodies | 816 |
within | 814 |
aml | 811 |
antigen | 803 |
host | 800 |
tumors | 798 |
hiv | 796 |
diseases | 793 |
antibody | 791 |
complications | 790 |
inflammatory | 789 |
nk | 788 |
pre | 783 |
underwent | 782 |
immunodeficiency | 778 |
symptoms | 775 |
cr | 769 |
recipients | 767 |
samples | 765 |
versus | 758 |
outcome | 757 |
although | 756 |
increase | 756 |
important | 754 |
presence | 753 |
population | 753 |
outcomes | 753 |
receptor | 749 |
engraftment | 744 |
liver | 741 |
university | 739 |
potential | 739 |
detected | 737 |
rare | 733 |
followed | 732 |
responses | 731 |
cohort | 727 |
male | 725 |
lung | 725 |
proliferation | 721 |
agvhd | 720 |
complete | 719 |
none | 710 |
single | 709 |
center | 704 |
period | 700 |
cause | 697 |
evaluated | 694 |
tissue | 692 |
second | 689 |
free | 687 |
respiratory | 687 |
matched | 685 |
new | 682 |
pcr | 682 |
history | 682 |
recurrent | 681 |
objectives | 680 |
unrelated | 679 |
status | 678 |
shown | 672 |
findings | 672 |
epstein | 670 |
skin | 665 |
lymphocytes | 664 |
ii | 661 |
barr | 658 |
healthy | 656 |
medical | 653 |
autologous | 650 |
carcinoma | 648 |
evaluation | 645 |
interest | 644 |
infectious | 643 |
mm | 642 |
decreased | 639 |
biopsy | 638 |
genes | 636 |
known | 636 |
considered | 634 |
like | 631 |
similar | 626 |
life | 625 |
will | 621 |
weeks | 620 |
demonstrated | 619 |
long | 619 |
proteins | 615 |
female | 614 |
ms | 613 |
addition | 613 |
production | 610 |
according | 608 |
test | 608 |
four | 603 |
infected | 603 |
care | 601 |
ifn | 595 |
iv | 595 |
refractory | 589 |
given | 589 |
induction | 586 |
reactivation | 583 |
novel | 581 |
previously | 581 |
haploidentical | 580 |
major | 578 |
features | 576 |
impact | 575 |
less | 573 |
described | 573 |
retrospective | 572 |
molecular | 569 |
presentation | 569 |
atg | 566 |
stage | 566 |
asct | 565 |
model | 564 |
family | 564 |
died | 563 |
count | 563 |
secondary | 560 |
progression | 555 |
term | 554 |
flow | 554 |
effective | 554 |
lymphocyte | 550 |
remission | 550 |
several | 547 |
seen | 544 |
lesions | 543 |
fever | 543 |
therapeutic | 542 |
required | 536 |
platelet | 536 |
pulmonary | 534 |
obtained | 532 |
death | 531 |
expressed | 531 |
assay | 530 |
elevated | 529 |
mediated | 526 |
conflict | 526 |
since | 526 |
dl | 524 |
despite | 523 |
cellular | 522 |
differences | 521 |
poor | 520 |
th | 518 |
autoimmune | 517 |
rates | 517 |
show | 516 |
confirmed | 515 |
cytokine | 513 |
aim | 510 |
large | 508 |
per | 503 |
standard | 500 |
adult | 500 |
loss | 500 |
difference | 499 |
vitro | 499 |
plasma | 497 |
kidney | 497 |
toxicity | 496 |
derived | 495 |
malignant | 494 |
small | 494 |
initial | 493 |
evidence | 493 |
criteria | 492 |
association | 491 |
table | 490 |
occurred | 490 |
pathology | 489 |
collected | 489 |
pain | 488 |
many | 488 |
characterized | 487 |
vaccine | 487 |
suggest | 485 |
disorders | 484 |
sequencing | 484 |
evaluate | 483 |
either | 482 |
receiving | 481 |
active | 481 |
csf | 480 |
dependent | 479 |
laboratory | 476 |
involved | 475 |
binding | 475 |
testing | 475 |
defined | 474 |
vivo | 473 |
efficacy | 472 |
five | 471 |
viruses | 470 |
controls | 469 |
management | 468 |
determine | 467 |
cgvhd | 466 |
improved | 465 |
better | 463 |
relapsed | 463 |
frequency | 462 |
sclerosis | 462 |
transplanted | 461 |
changes | 460 |
research | 457 |
review | 456 |
phenotype | 456 |
achieved | 455 |
pathway | 454 |
line | 453 |
systemic | 452 |
malignancies | 452 |
correlation | 451 |
target | 448 |
assessed | 447 |
limited | 447 |
diagnostic | 447 |
whether | 447 |
therefore | 446 |
possible | 445 |
recovery | 445 |
phase | 444 |
oral | 444 |
growth | 444 |
health | 443 |
previous | 442 |
organ | 440 |
chimerism | 440 |
myeloid | 439 |
characteristics | 439 |
co | 438 |
inflammation | 437 |
neutrophil | 432 |
haplo | 431 |
onset | 431 |
month | 431 |
signaling | 430 |
often | 430 |
hr | 430 |
combination | 429 |
weight | 427 |
scid | 426 |
available | 426 |
combined | 422 |
additional | 421 |
variant | 421 |
administration | 420 |
cord | 419 |
ct | 418 |
lines | 417 |
regimens | 416 |
anemia | 416 |
identify | 415 |
infusion | 415 |
detection | 414 |
breast | 413 |
cytometry | 412 |
stimulation | 411 |
might | 411 |
functional | 411 |
frequent | 410 |
course | 409 |
remains | 409 |
cyclophosphamide | 409 |
still | 408 |
even | 407 |
experience | 405 |
ratio | 404 |
score | 403 |
hepatitis | 403 |
whereas | 401 |
studied | 400 |
measured | 399 |
improvement | 397 |
bacterial | 397 |
result | 397 |
tcr | 395 |
iii | 395 |
scd | 394 |
individuals | 394 |
immunity | 392 |
pneumonia | 392 |
design | 392 |
activated | 391 |
lymph | 390 |
protocol | 390 |
events | 387 |
need | 385 |
support | 385 |
myeloablative | 383 |
six | 382 |
apoptosis | 381 |
caused | 379 |
least | 378 |
started | 378 |
value | 375 |
include | 374 |
drug | 374 |
igm | 372 |
examination | 372 |
order | 371 |
later | 371 |
via | 371 |
highly | 370 |
determined | 370 |
differentiation | 369 |
culture | 368 |
surface | 366 |
process | 366 |
busulfan | 365 |
whole | 364 |
introduction | 364 |
approach | 363 |
prognosis | 362 |
doses | 362 |
bm | 361 |
rna | 361 |
especially | 360 |
mrd | 358 |
memory | 358 |
immunoglobulin | 357 |
affected | 356 |
markers | 356 |
source | 355 |
replication | 354 |
inhibition | 354 |
mechanism | 353 |
intensity | 353 |
involvement | 353 |
investigated | 352 |
recent | 350 |
prospective | 349 |
mass | 349 |
decrease | 349 |
recipient | 349 |
assess | 348 |
reduction | 346 |
acid | 345 |
cytokines | 345 |
needed | 345 |
majority | 345 |
baseline | 345 |
setting | 344 |
screening | 344 |
leading | 344 |
invasive | 343 |
agents | 343 |
average | 342 |
hhv | 342 |
tested | 342 |
dli | 341 |
complex | 341 |
various | 340 |
provide | 339 |
mechanisms | 338 |
stat | 337 |
recently | 337 |
complication | 337 |
absence | 337 |
isolated | 335 |
subjects | 334 |
counts | 332 |
peptide | 332 |
episodes | 332 |
statistically | 332 |
improve | 332 |
disorder | 332 |
correlated | 332 |
likely | 331 |
pt | 330 |
epithelial | 330 |
describe | 329 |
safety | 328 |
malignancy | 327 |
retrospectively | 327 |
variants | 327 |
vaccination | 324 |
frequently | 324 |
undergoing | 323 |
adults | 323 |
mir | 323 |
pid | 321 |
rituximab | 320 |
macrophages | 319 |
currently | 319 |
antigens | 319 |
neutropenia | 319 |
central | 318 |
adverse | 318 |
prevalence | 317 |
prognostic | 317 |
quality | 315 |
regulation | 315 |
staining | 314 |
membrane | 313 |
series | 312 |
sibling | 312 |
body | 312 |
declare | 312 |
conditions | 311 |
independent | 310 |
trial | 310 |
duration | 310 |
left | 310 |
inhibitor | 310 |
class | 309 |
influenza | 309 |
underlying | 309 |
fludarabine | 308 |
steroid | 308 |
good | 307 |
values | 307 |
main | 306 |
established | 306 |
week | 305 |
last | 305 |
tract | 304 |
mild | 304 |
molecules | 303 |
significance | 302 |
tnf | 302 |
consistent | 302 |
cm | 302 |
administered | 302 |
mobilization | 302 |
nothing | 302 |
transfusion | 302 |
work | 300 |
auto | 300 |
inhibitors | 300 |
histological | 300 |
site | 298 |
van | 298 |
causes | 298 |
mds | 297 |
release | 297 |
resulting | 296 |
index | 296 |
assays | 295 |
ebna | 295 |
progressive | 294 |
procedure | 294 |
cvid | 294 |
united | 294 |
literature | 293 |
pattern | 293 |
brain | 292 |
parameters | 292 |
develop | 292 |
iga | 291 |
linked | 290 |
tlr | 290 |
immunosuppression | 290 |
reaction | 290 |
cycle | 290 |
late | 289 |
heterozygous | 289 |
ecp | 288 |
lead | 288 |
die | 288 |
exposure | 287 |
regulatory | 287 |
part | 287 |
cgd | 286 |
persistent | 285 |
form | 285 |
manifestations | 285 |
current | 285 |
myeloma | 284 |
parents | 283 |
states | 282 |
hlh | 282 |
containing | 282 |
numbers | 282 |
end | 280 |
strategy | 280 |
receptors | 280 |
pathogenic | 280 |
beta | 279 |
subsets | 278 |
cumulative | 278 |
resulted | 277 |
solid | 276 |
types | 276 |
generation | 276 |
lack | 276 |
abstract | 275 |
reconstitution | 275 |
moderate | 275 |
reports | 274 |
vod | 273 |
furthermore | 273 |
abnormalities | 273 |
seven | 273 |
alive | 273 |
contrast | 272 |
hsv | 271 |
alone | 271 |
antiviral | 271 |
dc | 271 |
biopsies | 270 |
pfs | 270 |
infants | 269 |
metastatic | 269 |
immunohistochemical | 267 |
mouse | 267 |
right | 267 |
abnormal | 266 |
immunosuppressive | 266 |
fungal | 266 |
selected | 266 |
suggesting | 266 |
hematological | 265 |
partial | 265 |
size | 265 |
statistical | 265 |
therapies | 265 |
transplants | 264 |
daily | 264 |
targeted | 264 |
investigate | 263 |
variable | 263 |
young | 263 |
comparison | 262 |
severity | 262 |
alternative | 262 |
hours | 262 |
surgical | 261 |
experienced | 261 |
reviewed | 260 |
consisted | 260 |
able | 260 |
nrm | 260 |
st | 260 |
ra | 259 |
january | 259 |
full | 259 |
transcription | 258 |
monitoring | 258 |
noted | 257 |
national | 257 |
department | 257 |
information | 257 |
key | 257 |
diffuse | 256 |
play | 256 |
nuclear | 256 |
presenting | 256 |
moreover | 255 |
wt | 255 |
mud | 255 |
percentage | 254 |
deficient | 254 |
consecutive | 254 |
morbidity | 253 |
change | 252 |
sarcoma | 252 |
clinically | 252 |
tests | 252 |
region | 250 |
abdominal | 250 |
program | 250 |
ric | 250 |
multivariate | 250 |
regarding | 249 |
expansion | 249 |
cytomegalovirus | 249 |
bleeding | 248 |
marker | 248 |
csa | 248 |
conducted | 248 |
made | 247 |
analyses | 247 |
mainly | 247 |
demonstrate | 247 |
strategies | 247 |
occur | 247 |
pathogenesis | 247 |
tumour | 247 |
ptcy | 246 |
subsequent | 246 |
particularly | 246 |
concentration | 245 |
option | 245 |
thrombocytopenia | 245 |
unknown | 245 |
genome | 245 |
der | 244 |
usually | 244 |
cy | 244 |
requiring | 243 |
gastrointestinal | 243 |
mixed | 243 |
gamma | 242 |
ability | 242 |
admission | 242 |
remained | 241 |
assessment | 241 |
collection | 241 |
intracellular | 241 |
eight | 241 |
lesion | 240 |
depletion | 240 |
oncology | 240 |
institute | 239 |
childhood | 239 |
ng | 238 |
monoclonal | 238 |
pi | 238 |
en | 238 |
intestinal | 238 |
cultures | 237 |
dept | 237 |
selection | 237 |
cytotoxic | 236 |
dysfunction | 236 |
carcinomas | 236 |
urine | 236 |
immunological | 236 |
signs | 235 |
times | 235 |
successful | 235 |
melphalan | 235 |
pathways | 234 |
short | 234 |
models | 234 |
intravenous | 233 |
pr | 233 |
formation | 233 |
aged | 233 |
injury | 232 |
elisa | 232 |
state | 232 |
induce | 232 |
reduce | 232 |
kinase | 231 |
quantitative | 231 |
males | 231 |
imaging | 230 |
steroids | 230 |
another | 230 |
us | 230 |
protective | 230 |
physical | 230 |
enrolled | 230 |
min | 230 |
general | 230 |
rejection | 229 |
tissues | 229 |
developing | 229 |
capacity | 228 |
met | 228 |
pbsc | 228 |
increasing | 228 |
identical | 227 |
essential | 227 |
influence | 227 |
identification | 227 |
optimal | 226 |
twenty | 226 |
atypical | 226 |
ivig | 226 |
neutrophils | 226 |
prolonged | 225 |
defects | 225 |
cyclosporine | 225 |
lymphomas | 225 |
prevent | 225 |
drugs | 225 |
urinary | 225 |
lymphoproliferative | 225 |
node | 225 |
commonly | 224 |
populations | 224 |
hemophagocytic | 224 |
surgery | 224 |
stable | 224 |
direct | 224 |
alpha | 224 |
vascular | 223 |
side | 223 |
centers | 223 |
institution | 223 |
females | 222 |
agent | 222 |
rapid | 222 |
und | 221 |
monocytes | 221 |
unit | 221 |
subsequently | 221 |
products | 221 |
curative | 221 |
examined | 221 |
replacement | 221 |
sample | 221 |
continued | 220 |
differential | 220 |
profile | 220 |
event | 220 |
hodgkin | 219 |
critical | 219 |
hps | 219 |
lmp | 219 |
hl | 219 |
older | 218 |
immunology | 218 |
ctla | 218 |
tbi | 218 |
useful | 218 |
infused | 218 |
antibiotics | 218 |
chain | 217 |
lymphopenia | 217 |
mhc | 217 |
strong | 217 |
generated | 216 |
greater | 216 |
led | 215 |
specimens | 215 |
peptides | 215 |
done | 214 |
estimated | 214 |
endothelial | 214 |
regression | 214 |
safe | 214 |
child | 213 |
interactions | 213 |
future | 213 |
bcl | 213 |
resistant | 213 |
ul | 212 |
extensive | 212 |
cycles | 212 |
analysed | 212 |
nhl | 212 |
mrna | 211 |
mri | 211 |
suggests | 211 |
documented | 211 |
women | 211 |
initiation | 211 |
resolution | 211 |
every | 211 |
hematology | 210 |
expressing | 210 |
sequence | 210 |
local | 210 |
advanced | 210 |
panel | 209 |
indicated | 209 |
distinct | 208 |
cross | 208 |
pd | 208 |
sites | 207 |
herpes | 207 |
approximately | 207 |
spectrum | 207 |
interaction | 207 |
procedures | 206 |
tacrolimus | 206 |
gd | 206 |
autoimmunity | 206 |
product | 206 |
maintenance | 206 |
relationship | 205 |
targeting | 205 |
best | 205 |
compare | 205 |
third | 205 |
successfully | 204 |
date | 204 |
impaired | 204 |
effector | 204 |
distribution | 203 |
medicine | 203 |
grafts | 203 |
natural | 203 |
car | 203 |
damage | 202 |
metastasis | 202 |
terms | 202 |
absolute | 202 |
stimulated | 202 |
knowledge | 202 |
complement | 202 |
lymphoid | 202 |
gi | 202 |
potentially | 201 |
dendritic | 201 |
condition | 201 |
help | 201 |
length | 201 |
cutaneous | 200 |
areas | 200 |
aki | 200 |
receive | 200 |
self | 200 |
importance | 200 |
enhanced | 200 |
pathological | 199 |
real | 199 |
sepsis | 199 |
susceptibility | 198 |
nine | 197 |
colitis | 197 |
finally | 197 |
recombinant | 196 |
titers | 196 |
nodes | 195 |
conventional | 195 |
cns | 194 |
positivity | 194 |
appropriate | 194 |
fibrosis | 194 |
latent | 194 |
next | 193 |
volume | 193 |
shows | 193 |
initiated | 192 |
pro | 192 |
sex | 192 |
clinic | 192 |
load | 192 |
ki | 191 |
immunohistochemistry | 191 |
cardiac | 191 |
comparable | 191 |
together | 190 |
authors | 190 |
plerixafor | 190 |
een | 190 |
origin | 190 |
additionally | 189 |
published | 189 |
initially | 189 |
upper | 188 |
hematologic | 188 |
hepatic | 188 |
pathogens | 188 |
gp | 187 |
platelets | 187 |
red | 187 |
bmt | 187 |
innate | 187 |
transfer | 186 |
ige | 186 |
scores | 186 |
particular | 186 |
longer | 186 |
diarrhea | 186 |
yet | 186 |
referred | 186 |
area | 186 |
outbreak | 185 |
sirolimus | 185 |
contribute | 185 |
ig | 185 |
relevant | 185 |
indicate | 185 |
salvage | 185 |
functions | 184 |
now | 184 |
affect | 184 |
interferon | 184 |
copies | 184 |
ptld | 183 |
clear | 183 |
allosct | 183 |
congenital | 183 |
hypogammaglobulinemia | 183 |
vitamin | 182 |
necessary | 182 |
interestingly | 182 |
gender | 182 |
intensive | 182 |
domain | 182 |
trials | 182 |
nf | 181 |
suspected | 181 |
exome | 181 |
survivors | 181 |
point | 181 |
icu | 180 |
transfusions | 180 |
multi | 180 |
herpesvirus | 180 |
completed | 180 |
admitted | 179 |
serious | 179 |
heart | 179 |
organs | 179 |
larger | 179 |
remain | 179 |
thymic | 179 |
hemoglobin | 179 |
minimal | 178 |
suggested | 178 |
resistance | 178 |
ck | 178 |
tma | 178 |
reactive | 178 |
remaining | 178 |
produced | 178 |
lymphoblastic | 178 |
iron | 177 |
sensitivity | 177 |
registry | 177 |
weekly | 176 |
ruxolitinib | 176 |
centre | 176 |
practice | 176 |
murine | 176 |
depleted | 176 |
records | 175 |
chest | 175 |
prevention | 175 |
ongoing | 175 |
recurrence | 175 |
nd | 174 |
hospitalization | 174 |
guidelines | 174 |
benefit | 174 |
aimed | 174 |
pg | 174 |
proportion | 174 |
occurs | 174 |
excluded | 174 |
seems | 174 |
het | 174 |
cost | 173 |
pb | 173 |
concentrations | 173 |
efficient | 173 |
except | 173 |
subset | 172 |
regions | 172 |
metastases | 172 |
acquired | 172 |
necrosis | 172 |
starting | 172 |
applied | 172 |
tool | 172 |
western | 172 |
routine | 172 |
benign | 171 |
hypertension | 170 |
represent | 170 |
double | 170 |
trm | 169 |
targets | 169 |
treatments | 169 |
understanding | 169 |
residual | 168 |
relative | 168 |
bu | 168 |
provided | 168 |
apoptotic | 168 |
secretion | 168 |
intervention | 168 |
confirm | 167 |
dysregulation | 167 |
bacteria | 167 |
recognized | 167 |
relatively | 167 |
specificity | 166 |
methotrexate | 166 |
flu | 166 |
mismatched | 166 |
hsp | 166 |
suppression | 166 |
plus | 166 |
msd | 165 |
cancers | 165 |
treat | 165 |
degree | 165 |
intermediate | 165 |
ten | 165 |
infusions | 165 |
rag | 165 |
divided | 164 |
mononuclear | 164 |
unique | 164 |
germany | 164 |
prophylactic | 164 |
fold | 164 |
spleen | 163 |
difficult | 163 |
others | 163 |
delayed | 163 |
generally | 163 |
sickle | 163 |
deletion | 162 |
defect | 162 |
id | 162 |
creatinine | 162 |
invasion | 162 |
adolescents | 162 |
mirna | 162 |
cypa | 162 |
ph | 162 |
promising | 162 |
towards | 161 |
feasible | 161 |
mcl | 161 |
tolerated | 161 |
ada | 161 |
fluid | 161 |
vaccines | 161 |
adherence | 161 |
es | 160 |
provides | 160 |
vector | 160 |
cxcr | 160 |
treg | 160 |
gain | 160 |
mscs | 160 |
kit | 160 |
experimental | 160 |
application | 160 |
forms | 159 |
mature | 159 |
fusion | 159 |
univariate | 159 |
absent | 159 |
maturation | 159 |
ex | 158 |
biological | 158 |
im | 158 |
ad | 158 |
viremia | 158 |
autosomal | 158 |
sos | 157 |
regulated | 157 |
calculated | 157 |
infiltration | 157 |
scan | 157 |
calcium | 157 |
components | 157 |
variables | 157 |
promoter | 156 |
thalassemia | 156 |
investigation | 156 |
tuberculosis | 156 |
predictive | 156 |
controlled | 155 |
signal | 155 |
analyze | 155 |
showing | 155 |
febrile | 155 |
participants | 155 |
points | 155 |
globulin | 155 |
beam | 155 |
adenovirus | 154 |
apheresis | 154 |
start | 154 |
ligand | 154 |
detect | 154 |
egfr | 153 |
posttransplant | 153 |
birth | 153 |
species | 153 |
occurrence | 152 |
december | 152 |
stress | 152 |
efs | 152 |
individual | 152 |
aggressive | 151 |
added | 151 |
injection | 151 |
expanded | 151 |
homozygous | 151 |
sle | 151 |
failed | 151 |
far | 150 |
bladder | 150 |
er | 150 |
sequences | 150 |
hd | 150 |
enzyme | 150 |
dfs | 150 |
antibiotic | 149 |
rt | 149 |
classified | 149 |
families | 149 |
strongly | 149 |
crucial | 149 |
animals | 149 |
dcs | 149 |
bei | 148 |
involving | 148 |
basis | 148 |
proteinuria | 148 |
terminal | 148 |
lymphohistiocytosis | 148 |
mmf | 148 |
light | 148 |
finding | 148 |
transformation | 148 |
variety | 147 |
phosphorylation | 147 |
corticosteroids | 147 |
recommended | 146 |
preliminary | 146 |
almost | 146 |
measles | 146 |
broad | 146 |
gut | 146 |
hpv | 146 |
mostly | 146 |
text | 146 |
ca | 145 |
require | 145 |
reached | 145 |
half | 145 |
stained | 145 |
leads | 144 |
stages | 144 |
colon | 144 |
tolerance | 144 |
radiation | 143 |
allograft | 143 |
threatening | 143 |
ctls | 143 |
approved | 143 |
molecule | 143 |
recognition | 143 |
responded | 142 |
complicated | 142 |
component | 142 |
properties | 142 |
classification | 142 |
disseminated | 142 |
kshv | 142 |
bk | 142 |
highest | 142 |
reactions | 141 |
chart | 141 |
expected | 141 |
hcmv | 141 |
responsible | 141 |
clones | 141 |
experiments | 141 |
along | 141 |
predominantly | 141 |
plays | 140 |
allohsct | 140 |
ns | 140 |
nkt | 140 |
represents | 140 |
pet | 140 |
fish | 139 |
fatal | 139 |
nih | 139 |
fully | 139 |
newly | 139 |
affecting | 138 |
granulomatous | 138 |
cytotoxicity | 138 |
bilateral | 138 |
sd | 138 |
immunocompromised | 138 |
genotype | 138 |
immunotherapy | 137 |
challenge | 137 |
inhibitory | 137 |
must | 137 |
syndromes | 137 |
taken | 137 |
rats | 137 |
lymphadenopathy | 137 |
patterns | 137 |
already | 136 |
sensitive | 136 |
illness | 136 |
causing | 136 |
interval | 136 |
rash | 136 |
specifically | 136 |
little | 135 |
muscle | 135 |
bacteremia | 135 |
deaths | 135 |
survey | 135 |
mirnas | 134 |
processing | 134 |
overexpression | 134 |
etiology | 134 |
database | 134 |
irradiation | 134 |
lps | 134 |
malaria | 134 |
caspase | 134 |
delay | 134 |
monitored | 134 |
allele | 133 |
hc | 133 |
performance | 133 |
allergic | 133 |
dominant | 133 |
tcd | 133 |
amplification | 133 |
foxp | 132 |
metabolic | 132 |
mit | 131 |
gastric | 131 |
hypothesis | 131 |
interstitial | 131 |
wild | 131 |
dosing | 131 |
medium | 131 |
efficiency | 131 |
rather | 131 |
mtx | 131 |
purified | 131 |
set | 131 |
inkt | 130 |
decision | 130 |
younger | 130 |
thiotepa | 130 |
randomized | 130 |
past | 130 |
restricted | 129 |
appears | 129 |
microscopy | 129 |
ebmt | 129 |
school | 129 |
anc | 129 |
reference | 129 |
treosulfan | 129 |
newborn | 129 |
proven | 129 |
thirty | 129 |
soluble | 129 |
ccr | 129 |
become | 128 |
approaches | 128 |
humoral | 128 |
tregs | 128 |
exon | 128 |
gata | 128 |
neuroblastoma | 128 |
trec | 128 |
directly | 128 |
cultured | 128 |
infant | 128 |
recorded | 128 |
directed | 128 |
probability | 128 |
processes | 128 |
mmp | 127 |
mycophenolate | 127 |
mononucleosis | 127 |
extremely | 127 |
induces | 127 |
msc | 127 |
dr | 127 |
exposed | 127 |
interleukin | 127 |
amino | 127 |
indicating | 127 |
genomic | 127 |
chromosome | 127 |
context | 126 |
typical | 126 |
tgf | 126 |
catenin | 126 |
supported | 126 |
von | 126 |
delivery | 126 |
international | 126 |
unclear | 125 |
etoposide | 125 |
diagnoses | 125 |
pregnancy | 125 |
resolved | 125 |
adenocarcinoma | 124 |
cohorts | 124 |
members | 124 |
splenomegaly | 124 |
sera | 124 |
protection | 124 |
encoded | 124 |
ctl | 124 |
options | 124 |
bowel | 124 |
mutant | 124 |
consolidation | 124 |
repertoire | 123 |
toxicities | 123 |
implicated | 123 |
latency | 123 |
earlier | 123 |
circulating | 123 |
comparing | 123 |
increases | 122 |
contact | 122 |
migration | 122 |
predicted | 122 |
ferritin | 122 |
immunization | 122 |
occurring | 121 |
cytopenias | 121 |
pbmcs | 121 |
resection | 121 |
macrophage | 121 |
typically | 121 |
animal | 121 |
adequate | 121 |
rarely | 121 |
example | 120 |
observation | 120 |
nervous | 120 |
endogenous | 120 |
making | 120 |
express | 120 |
ifng | 120 |
strain | 120 |
twice | 120 |
wide | 120 |
immunodeficiencies | 120 |
diabetes | 119 |
mast | 119 |
predict | 119 |
modified | 119 |
ranging | 119 |
marked | 119 |
cox | 119 |
dlbcl | 119 |
ibd | 119 |
cervical | 118 |
neurological | 118 |
asymptomatic | 118 |
stromal | 118 |
burden | 118 |
focal | 118 |
produce | 118 |
autoantibodies | 118 |
thyroid | 118 |
achieve | 118 |
gt | 118 |
wbc | 118 |
eligible | 118 |
subtypes | 118 |
adv | 117 |
po | 117 |
located | 117 |
epitope | 117 |
countries | 117 |
continuous | 117 |
hb | 117 |
producing | 117 |
signalling | 117 |
bl | 117 |
born | 117 |
protocols | 117 |
tki | 117 |
home | 117 |
situ | 117 |
around | 116 |
aa | 116 |
final | 116 |
adhesion | 116 |
compound | 116 |
biomarkers | 116 |
though | 116 |
carried | 116 |
immunologic | 116 |
squamous | 116 |
fact | 116 |
men | 116 |
allows | 115 |
correlations | 115 |
cytoplasmic | 115 |
white | 115 |
classical | 115 |
percent | 115 |
episode | 115 |
phenotypes | 115 |
usa | 115 |
estimates | 115 |
altered | 115 |
understand | 115 |
alterations | 115 |
ckd | 114 |
validated | 114 |
extracellular | 114 |
software | 114 |
includes | 114 |
sequential | 114 |
repair | 114 |
medications | 114 |
rapidly | 114 |
pathogen | 113 |
gm | 113 |
neoplastic | 113 |
clearance | 113 |
defibrotide | 113 |
technology | 113 |
completely | 113 |
arthritis | 113 |
certain | 113 |
cut | 113 |
systems | 112 |
varicella | 112 |
communication | 112 |
encoding | 112 |
allergy | 112 |
discharge | 112 |
melanoma | 112 |
transfected | 112 |
jak | 112 |
amount | 112 |
yield | 112 |
log | 111 |
alk | 111 |
depending | 111 |
poorly | 111 |
rd | 111 |
scale | 111 |
card | 111 |
transduction | 111 |
strains | 111 |
respond | 111 |
qol | 111 |
viability | 110 |
neoplasm | 110 |
tubular | 110 |
blasts | 110 |
needs | 110 |
corresponding | 110 |
favorable | 110 |
hies | 110 |
eine | 110 |
tumours | 110 |
sustained | 110 |
hand | 109 |
actin | 109 |
polymerase | 109 |
heterogeneous | 109 |
braf | 109 |
antifungal | 109 |
worse | 109 |
allow | 109 |
purpose | 109 |
trend | 109 |
mel | 109 |
rsv | 109 |
differentiated | 109 |
basal | 108 |
live | 108 |
establish | 108 |
team | 108 |
diversity | 108 |
aplastic | 108 |
material | 108 |
affects | 108 |
detectable | 108 |
mac | 108 |
hydroxyurea | 108 |
much | 107 |
providers | 107 |
ranged | 107 |
prednisone | 107 |
lymphocytic | 107 |
colorectal | 107 |
paediatric | 107 |
spontaneous | 107 |
responders | 107 |
exosomes | 107 |
repeat | 107 |
screen | 107 |
mesenchymal | 107 |
across | 106 |
adaptive | 106 |
degradation | 106 |
copy | 106 |
cystic | 106 |
novo | 106 |
requires | 106 |
ab | 106 |
kb | 106 |
indication | 106 |
make | 106 |
humans | 106 |
neutralizing | 106 |
flt | 106 |
subtype | 106 |
problem | 106 |
find | 106 |
epitopes | 106 |
tyrosine | 106 |
deficiencies | 106 |
engrafted | 106 |
mucositis | 106 |
zu | 106 |
project | 105 |
killer | 105 |
inclusion | 105 |
ligands | 105 |
impairment | 105 |
density | 105 |
characterize | 105 |
problems | 105 |
possibility | 105 |
ages | 105 |
focus | 105 |
define | 105 |
hcv | 105 |
einer | 104 |
girl | 104 |
discontinued | 104 |
fluorescence | 104 |
recessive | 104 |
probably | 104 |
thymus | 104 |
social | 104 |
dock | 104 |
displayed | 104 |
relation | 104 |
mofetil | 104 |
potent | 103 |
hemorrhagic | 103 |
persistence | 103 |
lupus | 103 |
transition | 103 |
asthma | 103 |
november | 103 |
whose | 103 |
content | 103 |
gl | 103 |
lacking | 103 |
discussion | 103 |
synthesis | 103 |
fas | 103 |
man | 103 |
manner | 103 |
nephropathy | 103 |
pneumoniae | 102 |
conditioned | 102 |
venous | 102 |
consensus | 102 |
bp | 102 |
selective | 102 |
world | 102 |
vzv | 102 |
media | 102 |
pathologic | 102 |
china | 102 |
sections | 102 |
manifestation | 102 |
zoster | 102 |
numerous | 102 |
proposed | 102 |
unusual | 101 |
fixed | 101 |
bmi | 101 |
prostate | 101 |
mother | 101 |
sufficient | 101 |
candida | 101 |
exhibited | 101 |
turkey | 101 |
june | 101 |
became | 101 |
excellent | 101 |
prominent | 101 |
pressure | 101 |
throughout | 100 |
allogenic | 100 |
symptomatic | 100 |
idiopathic | 100 |
implications | 100 |
supportive | 100 |
papillary | 100 |
similarly | 100 |
training | 99 |
blot | 99 |
om | 99 |
leukemic | 99 |
clonal | 99 |
bcr | 99 |
accumulation | 99 |
proliferative | 99 |
translocation | 99 |
woman | 99 |
institutional | 99 |
phenotypic | 99 |
ps | 99 |
fraction | 99 |
consent | 98 |
techniques | 98 |
naive | 98 |
detailed | 98 |
transient | 98 |
signals | 98 |
appear | 98 |
characterization | 98 |
lungs | 98 |
education | 98 |
units | 98 |
promote | 98 |
nature | 98 |
consisting | 98 |
neither | 98 |
ultrasound | 98 |
mucosa | 98 |
undergo | 98 |
excision | 98 |
uc | 98 |
accompanied | 98 |
cll | 98 |
mucosal | 97 |
pneumococcal | 97 |
widely | 97 |
ihc | 97 |
close | 97 |
maximum | 97 |
morphology | 97 |
plasmid | 97 |
siblings | 97 |
histology | 97 |
leukocyte | 97 |
enhance | 97 |
differ | 97 |
alps | 97 |
myelodysplastic | 97 |
symptom | 97 |
repeated | 97 |
composed | 96 |
microvesicles | 96 |
mab | 96 |
action | 96 |
profiles | 96 |
missense | 96 |
medication | 96 |
open | 96 |
boy | 96 |
environmental | 96 |
alemtuzumab | 96 |
adoptive | 96 |
core | 95 |
beneficial | 95 |
bkv | 95 |
cytoplasm | 95 |
transferred | 95 |
avoid | 95 |
recruitment | 95 |
inherited | 95 |
particles | 95 |
ahsct | 95 |
herpesviruses | 95 |
way | 95 |
hemolytic | 95 |
possibly | 95 |
july | 94 |
dialysis | 94 |
obstruction | 94 |
processed | 94 |
defective | 94 |
imatinib | 94 |
global | 94 |
search | 94 |
cxcl | 94 |
surveillance | 94 |
reasons | 94 |
yrs | 94 |
subcutaneous | 94 |
hscs | 94 |
aspergillus | 94 |
immediate | 93 |
neonatal | 93 |
morphological | 93 |
dexamethasone | 93 |
isolation | 93 |
soft | 93 |
nkg | 93 |
npc | 93 |
location | 93 |
lipid | 93 |
elderly | 93 |
step | 93 |
screened | 93 |
interventions | 92 |
neutropenic | 92 |
american | 92 |
considering | 92 |
rbc | 92 |
outpatient | 92 |
stimulating | 92 |
antimicrobial | 92 |
characteristic | 92 |
bortezomib | 92 |
cystitis | 92 |
phox | 92 |
choice | 92 |
goal | 92 |
suffered | 92 |
hsc | 92 |
inhibit | 92 |
histopathological | 92 |
regulate | 91 |
image | 91 |
calcineurin | 91 |
inhibited | 91 |
recovered | 91 |
gram | 91 |
candidate | 91 |
transcriptional | 91 |
april | 91 |
technique | 91 |
italy | 91 |
thereby | 91 |
pca | 91 |
extended | 91 |
lytic | 90 |
cytarabine | 90 |
sp | 90 |
prospectively | 90 |
uncommon | 90 |
demographic | 90 |
iqr | 90 |
domains | 90 |
measure | 90 |
endemic | 90 |
quantification | 90 |
japan | 90 |
aspects | 90 |
nasopharyngeal | 90 |
cidofovir | 90 |
correlate | 89 |
notable | 89 |
appeared | 89 |
proteasome | 89 |
primarily | 89 |
enriched | 89 |
informed | 89 |
submitted | 89 |
activating | 89 |
histologic | 89 |
akt | 89 |
ta | 89 |
october | 89 |
bcg | 89 |
stay | 89 |
hbv | 89 |
seem | 89 |
bal | 89 |
immunoglobulins | 89 |
largely | 89 |
cb | 89 |
transformed | 89 |
suffering | 88 |
extent | 88 |
ae | 88 |
hybridization | 88 |
measures | 88 |
exact | 88 |
reactivity | 88 |
variability | 88 |
covid | 88 |
access | 88 |
clearly | 88 |
albumin | 88 |
ist | 88 |
simplex | 88 |
enteropathy | 88 |
improving | 88 |
mobilized | 87 |
hyperplasia | 87 |
paraffin | 87 |
diagnose | 87 |
iu | 87 |
cytogenetic | 87 |
mo | 87 |
correlates | 87 |
neoplasms | 87 |
forty | 87 |
elements | 87 |
peak | 87 |
hospitalized | 87 |
tb | 87 |
adjuvant | 87 |
acids | 87 |
localized | 87 |
cadherin | 86 |
reducing | 86 |
seropositive | 86 |
september | 86 |
nausea | 86 |
apc | 86 |
evs | 86 |
familial | 86 |
reverse | 86 |
pancreatic | 86 |
maintained | 86 |
neurologic | 86 |
micrornas | 86 |
atopic | 86 |
depression | 86 |
myc | 86 |
staff | 86 |
always | 86 |
standardized | 86 |
subject | 86 |
nephrotic | 86 |
tetanus | 86 |
adjusted | 85 |
pc | 85 |
allohct | 85 |
fatigue | 85 |
treating | 85 |
ganciclovir | 85 |
affinity | 85 |
bij | 85 |
evolution | 85 |
encephalitis | 85 |
fetal | 85 |
nasal | 85 |
incubated | 85 |
respect | 85 |
mismatch | 85 |
see | 85 |
slightly | 85 |
neck | 85 |
delta | 85 |
matrix | 84 |
ds | 84 |
definitive | 84 |
opportunistic | 84 |
bplf | 84 |
activities | 84 |
distress | 84 |
pids | 84 |
vur | 84 |
device | 84 |
entire | 84 |
cure | 84 |
grfs | 84 |
evaluating | 84 |
linear | 84 |
minor | 84 |
ovarian | 84 |
allowed | 84 |
auc | 84 |
op | 84 |
reveal | 84 |
explore | 84 |
hormone | 84 |
hypothesized | 84 |
challenges | 84 |
act | 84 |
risks | 83 |
living | 83 |
consider | 83 |
reproductive | 83 |
compartment | 83 |
driven | 83 |
nuclei | 83 |
corticosteroid | 83 |
tac | 83 |
cc | 83 |
haematopoietic | 83 |
understood | 83 |
concern | 83 |
indicates | 83 |
thought | 83 |
means | 83 |
kinetics | 82 |
hematuria | 82 |
partially | 82 |
cerebral | 82 |
note | 82 |
ifi | 82 |
granulocyte | 82 |
structure | 82 |
pediatrics | 82 |
ec | 82 |
designed | 82 |
diverse | 82 |
influenced | 82 |
causative | 82 |
angiogenesis | 82 |
nearly | 82 |
success | 82 |
developmental | 82 |
substantial | 81 |
shock | 81 |
vectors | 81 |
appearance | 81 |
diameter | 81 |
vd | 81 |
immunomodulatory | 81 |
composition | 81 |
susceptible | 81 |
arm | 81 |
monocyte | 81 |
reason | 81 |
ma | 81 |
markedly | 81 |
gc | 81 |
gy | 81 |
examine | 81 |
employed | 81 |
cml | 81 |
ofp | 81 |
untreated | 81 |
ngs | 80 |
serve | 80 |
umbilical | 80 |
sources | 80 |
relapses | 80 |
trigger | 80 |
mc | 80 |
completion | 80 |
account | 80 |
emerging | 80 |
fc | 80 |
measurement | 80 |
preventing | 79 |
contained | 79 |
thymocyte | 79 |
mtor | 79 |
glycoprotein | 79 |
managed | 79 |
comprehensive | 79 |
ras | 79 |
demonstrates | 79 |
localization | 79 |
lymphatic | 79 |
closely | 79 |
concomitant | 79 |
dermatitis | 79 |
special | 79 |
somatic | 79 |
radiotherapy | 79 |
aims | 79 |
gland | 79 |
igrt | 79 |
member | 78 |
august | 78 |
timing | 78 |
ucb | 78 |
helper | 78 |
profound | 78 |
maternal | 78 |
switched | 78 |
field | 78 |
extracted | 78 |
platform | 78 |
indications | 78 |
clinicians | 78 |
rs | 78 |
effectiveness | 78 |
rat | 78 |
pos | 78 |
march | 78 |
importantly | 78 |
suggestive | 78 |
monthly | 78 |
phage | 78 |
vomiting | 77 |
suitable | 77 |
des | 77 |
chimeric | 77 |
rank | 77 |
minutes | 77 |
qpcr | 77 |
nef | 77 |
lost | 77 |
del | 77 |
workup | 77 |
pp | 77 |
superior | 77 |
occlusive | 77 |
people | 77 |
measuring | 77 |
follicular | 77 |
precursor | 77 |
polymorphism | 77 |
hemorrhage | 77 |
generate | 77 |
multicenter | 77 |
mycobacterial | 77 |
hu | 77 |
complexes | 76 |
conclude | 76 |
ova | 76 |
aids | 76 |
decline | 76 |
heavy | 76 |
systematic | 76 |
killing | 76 |
nfkb | 76 |
enzymes | 76 |
phases | 76 |
dysplasia | 76 |
mnc | 76 |
biochemical | 76 |
depends | 76 |
rest | 76 |
tc | 76 |
suspicion | 76 |
sat | 76 |
admissions | 76 |
haploinsufficiency | 76 |
changed | 76 |
called | 76 |
warranted | 76 |
eculizumab | 75 |
reliable | 75 |
proved | 75 |
cryopreserved | 75 |
costs | 75 |
shorter | 75 |
challenging | 75 |
kir | 75 |
prrs | 75 |
varied | 75 |
fifty | 75 |
transmission | 75 |
worsening | 75 |
pneumocystis | 75 |
roles | 75 |
acyclovir | 75 |
vegf | 75 |
functioning | 75 |
promotes | 75 |
frequencies | 75 |
progressed | 75 |
providing | 75 |
entity | 75 |
candidates | 75 |
variation | 74 |
availability | 74 |
environment | 74 |
inpatient | 74 |
sc | 74 |
physicians | 74 |
mutated | 74 |
latter | 74 |
gof | 74 |
putative | 74 |
contains | 74 |
lineage | 74 |
wall | 74 |
proinflammatory | 74 |
concerning | 74 |
autophagy | 74 |
highlights | 74 |
pnh | 74 |
nocturnal | 74 |
hyper | 73 |
sent | 73 |
periods | 73 |
polyclonal | 73 |
structures | 73 |
crs | 73 |
display | 73 |
facilitate | 73 |
pidd | 73 |
growing | 73 |
inhibits | 73 |
european | 73 |
subgroup | 73 |
abscess | 73 |
limitations | 73 |
leukocytes | 73 |
ic | 73 |
ubiquitin | 73 |
otherwise | 73 |
nodules | 73 |
clone | 73 |
progress | 73 |
splenectomy | 73 |
mf | 73 |
cpg | 72 |
regulator | 72 |
immediately | 72 |
entry | 72 |
splenic | 72 |
specimen | 72 |
taking | 72 |
adenocarcinomas | 72 |
fevers | 72 |
achieving | 72 |
letermovir | 72 |
lfs | 72 |
financial | 72 |
leukaemia | 72 |
scans | 72 |
rubella | 72 |
concurrent | 72 |
kaplan | 72 |
bound | 72 |
osteosarcoma | 72 |
observations | 72 |
parental | 72 |
spindle | 72 |
conserved | 72 |
ifd | 72 |
abo | 72 |
immature | 72 |
nephritis | 72 |
lymphoproliferation | 72 |
notably | 72 |
maintain | 71 |
section | 71 |
probe | 71 |
sub | 71 |
spinal | 71 |
joint | 71 |
wes | 71 |
implemented | 71 |
biology | 71 |
measurements | 71 |
great | 71 |
estimate | 71 |
septic | 71 |
food | 71 |
salivary | 71 |
rearrangement | 71 |
tg | 71 |
obtain | 71 |
cid | 71 |
ventilation | 71 |
decreasing | 71 |
independently | 71 |
microscopic | 71 |
existing | 71 |
oxygen | 71 |
bronchiectasis | 71 |
fa | 71 |
thymocytes | 71 |
undetectable | 71 |
shrna | 71 |
ks | 71 |
dmso | 71 |
mechanical | 71 |
questionnaire | 70 |
nbs | 70 |
separate | 70 |
guide | 70 |
boys | 70 |
recruited | 70 |
basic | 70 |
organisms | 70 |
rr | 70 |
crp | 70 |
summary | 70 |
lc | 70 |
immunized | 70 |
explain | 70 |
head | 70 |
otitis | 70 |
utilization | 70 |
reach | 70 |
hemolysis | 70 |
dengue | 70 |
subunit | 70 |
coli | 70 |
glomerular | 70 |
kidneys | 69 |
eczema | 69 |
placed | 69 |
transfection | 69 |
prevalent | 69 |
progenitor | 69 |
epidemiological | 69 |
ar | 69 |
enuresis | 69 |
stool | 69 |
microrna | 69 |
orip | 69 |
rabbit | 69 |
acceptable | 69 |
vessels | 69 |
structural | 69 |
oder | 69 |
mitogen | 69 |
division | 69 |
colony | 69 |
fragment | 69 |
embedded | 69 |
infectie | 69 |
epidemiology | 69 |
predictors | 69 |
limiting | 69 |
classic | 69 |
spain | 69 |
undergone | 69 |
incidences | 69 |
algorithm | 69 |
temperature | 69 |
granulocytes | 69 |
upregulation | 69 |
placebo | 69 |
nm | 68 |
transgenic | 68 |
ultimately | 68 |
plt | 68 |
smoking | 68 |
titer | 68 |
sds | 68 |
exhibit | 68 |
toxic | 68 |
nodular | 68 |
ag | 68 |
genetically | 68 |
itp | 68 |
recommendations | 68 |
alc | 68 |
intra | 68 |
inducing | 68 |
exam | 68 |
gcsf | 68 |
healthcare | 68 |
prepared | 68 |
ir | 68 |
evaluable | 68 |
courses | 68 |
attributed | 68 |
ev | 68 |
wound | 67 |
feasibility | 67 |
vasculitis | 67 |
society | 67 |
mitotic | 67 |
electronic | 67 |
address | 67 |
faculty | 67 |
identifying | 67 |
benefits | 67 |
lch | 67 |
beyond | 67 |
pf | 67 |
girls | 67 |
continue | 67 |
subgroups | 67 |
aureus | 67 |
biomarker | 67 |
removed | 67 |
pik | 67 |
mp | 67 |
flag | 67 |
african | 67 |
igan | 67 |
eventually | 67 |
facs | 67 |
twelve | 67 |
pk | 67 |
infektion | 66 |
match | 66 |
tnfa | 66 |
md | 66 |
pancytopenia | 66 |
eosinophilic | 66 |
ro | 66 |
protease | 66 |
hence | 66 |
door | 66 |
journal | 66 |
lab | 66 |
bv | 66 |
survived | 66 |
programs | 66 |
relevance | 66 |
original | 66 |
airway | 66 |
sh | 66 |
fluconazole | 66 |
contribution | 66 |
injected | 66 |
traits | 66 |
abscesses | 66 |
fibroblasts | 66 |
million | 66 |
transduced | 65 |
regard | 65 |
apds | 65 |
allowing | 65 |
persisted | 65 |
pbmc | 65 |
subpopulations | 65 |
peritoneal | 65 |
sr | 65 |
back | 65 |
werden | 65 |
advantage | 65 |
height | 65 |
ncf | 65 |
block | 65 |
categories | 65 |
fviii | 65 |
microbiota | 65 |
cough | 65 |
father | 65 |
rfs | 65 |
contain | 65 |
stopped | 65 |
supports | 65 |
frozen | 65 |
gfr | 65 |
conversion | 65 |
recognize | 65 |
parasite | 65 |
mmud | 65 |
regulating | 65 |